Now showing items 41-46 of 46
Comparison of standard versus low‐dose valganciclovir regimens for cytomegalovirus prophylaxis in high‐risk liver transplant recipients
(Wiley Periodicals, Inc., 2021-10)
PurposeThe purpose of this study was to compare the safety and efficacy of two valganciclovir (VGCV) institutional dosing protocols for cytomegalovirus (CMV) prophylaxis in liver transplant (LT) recipients with CMV serotype ...
The pandemic provides a pathway: What we know and what we need to know about using COVID positive donors
(Wiley Periodicals, Inc., 2021-10)
Low risk high reward: What should we worry about with coronavirus disease 2019 positive donors?
(Wiley Periodicals, Inc., 2022-08)
Into the unknown: Diagnosing mysterious brain lesions
(Wiley Periodicals, Inc., 2022-08)
In this inaugural clinicopathological conference, the invited experts discussed the diagnostic approach to central nervous system infections in immunocompromised hosts. The case presented involved a pancreas- kidney ...
Antimicrobial stewardship in solid organ transplant recipients: Current challenges and proposed metrics
(World health OrganizationWiley Periodicals, Inc., 2022-10)
BackgroundSolid organ transplant (SOT) recipients are challenging populations for antimicrobial stewardship interventions due to a variety of reasons, including immunosuppression, consequent risk of opportunistic and ...
Phage therapy in a lung transplant recipient with cystic fibrosis infected with multidrug-resistant Burkholderia multivorans
(Random HouseWiley Periodicals, Inc., 2023-04)
BackgroundThere is increased interest in bacteriophage (phage) therapy to treat infections caused by antibiotic-resistant bacteria. A lung transplant recipient with cystic fibrosis and Burkholderia multivorans infection ...